1. References
[1] W. H. Organization, Safe abortion: technical and policy guidance for health systems. World Health Organization, 2012.
[2] M. Krugh and C. V Maani, “Misoprostol,” 2019.
[3] M. Saha, A. Chakraborty, S. Chattopadhyay, S. Saha, J. Paul, and A. Das, “Effect of misoprostol for cervical priming before gynecological procedures on nonpregnant premenopausal women,” J. Nat. Sci. Biol. Med., vol. 6, no. Suppl 1, p. S123, 2015.
[4] H. Celik and E. Sapmaz, “Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy,” Fertil. Steril., vol. 79, no. 5, pp. 1207–1210, 2003.
[5] M. Abdel‐Hafeez, A. Elnaggar, M. Ali, A. M. Ismail, and M. Yacoub, “Rectal misoprostol for myomectomy: A randomised placebo‐controlled study,” Aust. New Zeal. J. Obstet. Gynaecol., vol. 55, no. 4, pp. 363–368, 2015.
[6] C. Fiala, K. Gemzell‐Danielsson, O. S. Tang, and H. Von Hertzen, “Cervical priming with misoprostol prior to transcervical procedures,” Int. J. Gynecol. Obstet., vol. 99, pp. S168–S171, 2007.
[7] “Management of Gestational Trophoblastic Disease,” BJOG An Int. J. Obstet. Gynaecol., vol. 128, no. 3, pp. e1–e27, Feb. 2021, doi: 10.1111/1471-0528.16266.
[8] F. Flam, V. Lundström, and F. Pettersson, “Medical induction prior to surgical evacuation of hydatidiform mole: is there a greater risk of persistent trophoblastic disease?,” Eur. J. Obstet. Gynecol. Reprod. Biol., vol. 42, no. 1, pp. 57–60, 1991.
[9] Paul Duggan et al., “The management of gestational trophoblastic disease,” R. Aust. New Zeal. Coll. Obstet. Gynaecol., Mar. 2020.
[10] J. A. Tidy, A. M. Gillespie, N. Bright, C. R. Radstone, R. E. Coleman, and B. W. Hancock, “Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy,” Gynecol. Oncol., vol. 78, no. 3, pp. 309–312, 2000.
2. Hemida R, Misoprostol for Cervical Ripening Prior to Molar Evacuation: A letter to the editor. J Obstet Gynecol Cancer Res. 2022; 7 (4): XX-XX
3. The Association of Gestational Trophoblastic Neoplasia and Misoprostol Administered Before Suction Curettage of Molar Pregnancy
4. World Health Organization, Safe abortion: technical and policy guidance for health systems. World Health Organization, 2012.
5. Krugh M, Maani CV. Misoprostol. [Updated 2021 Jul 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539873/